Human papillomavirus and HPV vaccines: a review - Wikidata - awgldk - TriplyDB

Human papillomavirus and HPV vaccines: a review

Human papillomavirus and HPV vaccines: a review

http://www.wikidata.org/entity/Q24657891

about

The role of infection in miscarriage Anti-cancer vaccines - a one-hit wonder?Are the currently existing anti-human papillomavirus vaccines appropriate for the developing world?Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study Technological Microbiology: Development and Applications Adverse events following HPV immunization in Australia: Establishment of a clinical network.Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia.Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009 On the implications of desexualizing vaccines against sexually transmitted diseases: health policy challenges in a multicultural society.Pathogen evolution and the immunological niche.Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development.Acceptability and correlates of primary and secondary prevention of cervical cancer among medical students in southwest China: implications for cancer education.Human papilloma virus vaccination programs reduce health inequity in most scenarios: a simulation study.Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence.Global challenges of implementing human papillomavirus vaccines.Intermediate heparan sulfate binding during HPV-16 infection in HaCaTs.Interventions to prevent sexually transmitted infections, including HIV infection.Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethio The prevention of infection-associated cancers Acceptability of study procedures (self-collected introital swabs, blood draws and stool sample collection) by students 10-16 years for an HPV vaccine effectiveness study: a pilot study CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice Human papillomavirus immunization is associated with increased expression of different innate immune regulatory receptors [Safety of human papillomavirus 6, 11, 16 and 18 (recombinant): systematic review and meta-analysis].Priority Setting for Improvement of Cervical Cancer Prevention in Iran Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy HPV vaccine uptake among overweight and obese US adolescents: An analysis of the National Health and Nutrition Examination Survey (NHANES) 2009-2014.An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice.Performance of a polymer-based DNA chip platform in detection and genotyping of human papillomavirus in clinical samples.Self-collected versus clinician-collected sampling for sexually transmitted infections: a systematic review and meta-analysis protocol.Bogarting that joint might decrease oral HPV among cannabis users Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesions Harnessing Nanoparticles for Immunomodulation and Vaccines Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries.Human papillomavirus: current status and issues of vaccination.HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.The potential of plants for the production and delivery of human papillomavirus vaccines.

P2860

Q26783142-6B890047-4636-4C85-B52C-3793F6C39C58 Q26995164-B8198961-F1EA-47A8-8168-69CC292D2D67 Q27692056-92050EAE-65AE-46B7-AD2E-8841D70C254C Q28084836-1A814F00-C86E-48D5-A97B-B1462A41EF5C Q28647510-7626DE45-3046-461C-9756-557D19F12B28 Q30250972-A1B44EAA-703C-43D4-B45D-46070DB77DFF Q33167293-EAB7E5BD-4049-4AC6-AEDD-1755730CEEDB Q33318134-9304FE51-00DE-4926-B767-BA7441784AC4 Q33633839-C26701AF-78D3-4E9C-A6D7-52403F0808B7 Q33713018-BB151D61-A723-4754-BDA7-583BEA872E4F Q33764218-FF3C2725-B864-4C71-A1C2-067BE16AC471 Q33861880-DB34D23A-9CB6-4944-9776-AED6D866FEF0 Q34078369-26B2C6BF-3263-457E-84E5-9706D3574D5A Q34116988-A93F7A88-952C-4E8C-A1E4-A4018C15D235 Q34434281-42CEEA57-E4DB-419B-B47D-F89874E0DF57 Q34462627-7DF424B9-545A-459A-9A65-AF734525959A Q35121855-00915C38-72EA-4B69-A9A8-1191DCAFEAAF Q35128768-8BC00D77-3726-4B07-97A8-4B0C1A58CFCD Q35379573-DEA3EC78-C126-413B-AFC4-2154105D623D Q35542152-90135C5B-9597-4B34-BDA8-CDB99D284A11 Q35786238-8DDED295-7802-433E-AA9D-40E1C1DA0702 Q35857515-3B3375B4-CF49-468F-89A8-B49AB555A347 Q35958294-071594AF-9052-4FD9-9E0E-F8C7761BB038 Q36029079-74F90F11-5975-46E0-AE6F-0FFC711916CB Q36071760-F4C1A532-692C-4B84-AFB2-78A16E65BE05 Q36086249-C2972D1E-9098-44C0-8106-89A04D101DA9 Q36388694-14CABF32-4EE5-496D-A09D-7EABFA43DF87 Q36760082-ADF23454-951E-46A3-971F-6323EF5F06FB Q36786011-F49AD684-8C0B-4B4F-BE5D-C8D01C52A092 Q36927328-4B17E897-8BD8-47EB-BA66-E50BA57E5678 Q37091134-983FA0E4-3F57-466B-83AC-7961356A8563 Q37191617-25FAE56C-D1E9-4A54-B1F3-CCA707BDF80A Q37365785-1AF3B76D-C52D-44AB-81FA-5105802B5B58 Q37479090-4635B237-8202-4D10-9EF4-01EE44DBDF00 Q37511930-33E2617E-E7A7-42E6-9A05-0949CC54D2F0 Q37727724-D5BEB90D-A2F4-4483-8310-3F9A97A0A59D Q37773300-F97F22C3-79C5-4480-9CFC-EEEE5A18198D Q38136127-68EA1EC1-5365-4EA9-A0F1-5973D094C45B Q38422886-69D5BB74-6C18-4250-90FD-0D1B40A3A3A0 Q38424974-835D03A4-4AB9-42F7-8FBB-FD27A773EE3C

P2860

Human papillomavirus and HPV vaccines: a review

http://www.wikidata.org/entity/Q24657891

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Human papillomavirus and HPV vaccines: a review

@ast

Human papillomavirus and HPV vaccines: a review

@en

Human papillomavirus and HPV vaccines: a review

@nl

type

label

Human papillomavirus and HPV vaccines: a review

@ast

Human papillomavirus and HPV vaccines: a review

@en

Human papillomavirus and HPV vaccines: a review

@nl

prefLabel

Human papillomavirus and HPV vaccines: a review

@ast

Human papillomavirus and HPV vaccines: a review

@en

Human papillomavirus and HPV vaccines: a review

@nl

P1433

Q24657891-4953ABA0-95EE-4E7A-ABFF-61441A4759B3

P1476

Q24657891-6CED53AB-C098-4261-A470-87287A70F828

P2093

Q24657891-3C688FF7-994C-4AE3-BC0B-561B3AC5F286

Q24657891-44D2973F-197C-45A3-B44F-CC778ACBC8DA

Q24657891-497D5D51-02EF-4F2E-8573-14AFD2187597

Q24657891-54695EF8-3BFE-4673-AE0E-F7FC9D0D314C

Q24657891-6D0C6CDA-A239-4155-9178-2CC92A4569DB

Q24657891-7D467209-A654-4B15-8585-9D3712CCC1BB

Q24657891-93D14BFE-FEDA-45E5-9F39-E28DB6176FDA

Q24657891-D9B9CB2D-26D8-44F2-8383-CB67C9AABE99

Q24657891-DA964131-7550-402E-BED3-8B17402F82F6

P2860

Q24657891-06BD2571-5D8E-44A8-8684-206EB4E58F28

Q24657891-1A2CDC63-9525-4F04-8525-F9FC5954B123

Q24657891-1A3EC321-B986-4CFF-9DB4-99DB00C6201D

Q24657891-23D1BD17-1445-4BB2-92B0-2ECADEA5B5B9

Q24657891-30077E7C-D02C-4146-8A44-32B693864968

Q24657891-31B8B911-7833-4415-8245-026EFD67DF74

Q24657891-35B844F4-5511-42BC-B781-C3EE58EDC693

Q24657891-35FCD9FF-6A37-46AB-B948-57F8620FEFCF

Q24657891-38AA0A60-0AE4-4B47-B8ED-F6C7EB179C4E

Q24657891-4D25475C-D8C1-49BC-B7ED-0C208274A279

P304

Q24657891-A120F262-1E96-4D25-8F74-B203A08370E2

P31

Q24657891-6382B26F-F5AD-4256-B54A-3298C1F2AB5D

P3181

Q24657891-D1E990B1-B5C4-45B5-85A5-C8E7B8E4697A

P356

Q24657891-12ED2FD5-05A3-4B3E-9B7F-F3BE11726BBD

P407

Q24657891-8535B450-DC1E-449D-9BF1-7FF0357967CE

P433

Q24657891-F1D901D3-04AB-4FF2-81A8-6F5B0B899159

P478

Q24657891-4D14ABFF-4E92-4BBF-A8E7-7B81BE540560

P50

Q24657891-5E049515-06B1-4D53-BB8E-5687772377F6

Q24657891-67E87DAB-C9B7-4F78-AD5F-5BFA6134DFFE

P577

Q24657891-70995918-8B4F-4F48-BD74-330A9B7A2333

P698

Q24657891-ACF8F089-F835-499C-8136-094E1833F1A2

P921

Q24657891-F3465073-7597-4FF2-8C2F-672E888CEF5A

P932

Q24657891-4F08B6BF-492B-42C1-B858-5648C8ACA9F0

P3181

P356

P1433

Bulletin of the World Health Organization

P1476

Human papillomavirus and HPV vaccines: a review

@en

P2093

D M Harper

http://www.w3.org/2001/XMLSchema#string

F T Cutts

http://www.w3.org/2001/XMLSchema#string

G Garnett

http://www.w3.org/2001/XMLSchema#string

K L Goldenthal

http://www.w3.org/2001/XMLSchema#string

L Markowitz

http://www.w3.org/2001/XMLSchema#string

P Claeys

http://www.w3.org/2001/XMLSchema#string

S Goldie

http://www.w3.org/2001/XMLSchema#string

S de Sanjose

http://www.w3.org/2001/XMLSchema#string

X Castellsague

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Condom use and the risk of genital human papillomavirus infection in young women

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

Human papillomavirus 16 infection in adenocarcinoma of the cervix

Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group.

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.

General acquisition of human papillomavirus infections of skin occurs in early infancy.

P304

719-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3983793

http://www.w3.org/2001/XMLSchema#string

P356

10.2471/BLT.06.038414

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Silvia Franceschi

W. John Edmunds

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18026629

http://www.w3.org/2001/XMLSchema#string

P921

P932

2636411

http://www.w3.org/2001/XMLSchema#string